Why prescription drug prices are plunging

# Why This Matters The sharp decline in prescription drug prices represents a fundamental shift in American healthcare economics that will ripple through household budgets, insurance premiums, and pharmaceutical industry investment decisions for years to come. For the roughly 130 million Americans who take prescription medications regularly, lower drug costs translate directly into reduced out-of-pocket expenses and breathing room in monthly healthcare spending that has been squeezed for decades. This deflation also eases pressure on insurance companies and employers, potentially allowing them to redirect savings toward other benefits or lower premium increases rather than absorbing rising drug costs as they have historically done. However, the sustainability of these price declines depends on whether they reflect genuine market competition and generic drug expansion, or temporary factors that could reverse—making the structural drivers behind this trend crucial for policymakers to understand and preserve.